GW Pharmaceuticals cannabis drug gets regulatory OK in Australia
GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in…
News September 24GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in…
News September 24Participation in British Columbia’s upcoming Indigenous Shelf Space Program will be voluntary for the province’s privately owned cannabis…
News September 23The number of authorized medical cannabis patients in Israel has more than doubled in the past two years…
News September 23Canadian marijuana producer Aurora Cannabis reported a net loss of more than 1.8 billion Canadian dollars ($1.4 billion)…
News September 22Florida-based cannabis traceability company Metrc locked down the contract for Oklahoma's medical marijuana program, bringing the firm's total…
News September 21Uruguayan authorities are blaming an administrative error for recent communication that medical cannabis shipments from the South American…
News September 21Manitoba’s provincial cannabis store regulator is considering a new type of cannabis business license that would allow on-site…
News September 21Shelf space in British Columbia's privately and publicly owned recreational cannabis stores will soon be reserved to highlight…
News September 21British Columbia is developing farm-gate and direct delivery programs to benefit cannabis industry businesses and expects them to…
News September 21Democrats in the U.S. House of Representatives decided this week to hold off on a floor vote for…
News September 19